ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,071,142 | -15.3% | 527,656 | -4.1% | 0.00% | – |
| Q2 2023 | $1,265,134 | +46.4% | 550,058 | +92.8% | 0.00% | – |
| Q1 2023 | $864,398 | +13278.7% | 285,280 | +10187.8% | 0.00% | – |
| Q4 2022 | $6,461 | -7.7% | 2,773 | -19.1% | 0.00% | – |
| Q3 2022 | $7,000 | -73.1% | 3,427 | -64.3% | 0.00% | – |
| Q2 2022 | $26,000 | -71.7% | 9,597 | -69.0% | 0.00% | – |
| Q1 2022 | $92,000 | -4.2% | 30,994 | +25.7% | 0.00% | – |
| Q4 2021 | $96,000 | +52.4% | 24,654 | +68.0% | 0.00% | – |
| Q3 2021 | $63,000 | +117.2% | 14,679 | +53.5% | 0.00% | – |
| Q2 2021 | $29,000 | -71.3% | 9,562 | -68.5% | 0.00% | – |
| Q1 2021 | $101,000 | -48.5% | 30,390 | -45.0% | 0.00% | – |
| Q4 2020 | $196,000 | +250.0% | 55,270 | +213.2% | 0.00% | – |
| Q3 2020 | $56,000 | +600.0% | 17,646 | +296.9% | 0.00% | – |
| Q2 2020 | $8,000 | -52.9% | 4,446 | -74.1% | 0.00% | – |
| Q1 2020 | $17,000 | -5.6% | 17,146 | +161.4% | 0.00% | – |
| Q4 2019 | $18,000 | +50.0% | 6,560 | -18.3% | 0.00% | – |
| Q3 2019 | $12,000 | -55.6% | 8,028 | -38.3% | 0.00% | – |
| Q2 2019 | $27,000 | -32.5% | 13,013 | +16.3% | 0.00% | – |
| Q1 2019 | $40,000 | -54.0% | 11,186 | -50.2% | 0.00% | – |
| Q4 2018 | $87,000 | -75.1% | 22,445 | -39.4% | 0.00% | – |
| Q3 2018 | $350,000 | +257.1% | 37,024 | +174.8% | 0.00% | – |
| Q2 2018 | $98,000 | +308.3% | 13,473 | +181.5% | 0.00% | – |
| Q1 2018 | $24,000 | +20.0% | 4,786 | +20.1% | 0.00% | – |
| Q4 2017 | $20,000 | -81.3% | 3,984 | -76.8% | 0.00% | – |
| Q3 2017 | $107,000 | +167.5% | 17,196 | +55.0% | 0.00% | – |
| Q2 2017 | $40,000 | -32.2% | 11,096 | -38.9% | 0.00% | – |
| Q1 2017 | $59,000 | -88.0% | 18,160 | -91.0% | 0.00% | – |
| Q4 2016 | $492,000 | -2.6% | 200,960 | +36.9% | 0.00% | – |
| Q3 2016 | $505,000 | +3.5% | 146,760 | +4.6% | 0.00% | – |
| Q2 2016 | $488,000 | +16.5% | 140,260 | +38.2% | 0.00% | – |
| Q1 2016 | $419,000 | +210.4% | 101,501 | +233.3% | 0.00% | – |
| Q4 2015 | $135,000 | -38.4% | 30,450 | -15.7% | 0.00% | – |
| Q3 2015 | $219,000 | – | 36,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |